BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16988092)

  • 1. Expression of concern - Sudbo J. Novel management of oral cancer: a paradigm of predictive oncology. Clin Med Res 2004;2:233-242.
    Dart RA; Salzman-Scott SA
    Clin Med Res; 2006 Sep; 4(3):160. PubMed ID: 16988092
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of concern: Sudbø J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8 and Sudbø J et al. the influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004;350:1405-13.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2006 Feb; 354(6):638. PubMed ID: 16428677
    [No Abstract]   [Full Text] [Related]  

  • 3. Retraction - Sudbo J. Novel management of oral cancer: a paradigm of predictive oncology. Clin Med Res 2004;2:233-242.
    Reed KD; Salzman-Scott SA
    Clin Med Res; 2007 Oct; 5(3):203. PubMed ID: 18056030
    [No Abstract]   [Full Text] [Related]  

  • 4. Oral cancer: a preventable disease?
    Toth BB; Weber RS; Hong WK
    Tex Dent J; 1988 Jun; 105(6):8-11. PubMed ID: 3217894
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemoprevention as a form of cancer control.
    Toth BB; Martin JW; Lippman SM; Hong WK
    J Am Dent Assoc; 1993 Jul; 124(7):243-6. PubMed ID: 8335795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The early diagnosis and prevention of oral precancer and cancer.
    Altini M
    S Afr Med J; 1989 Feb; Suppl():1. PubMed ID: 2916167
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitamin A related compounds in the chemoprevention of potentially malignant oral lesions and carcinoma.
    Scully C; Boyle P
    Eur J Cancer B Oral Oncol; 1992 Oct; 28B(2):87-9. PubMed ID: 1306733
    [No Abstract]   [Full Text] [Related]  

  • 8. [Procedure for prevention of the carcinomatous transformation of oral lichen ruber planus].
    Bucci E; Monaco A; Calabrese E; Sorrentino F
    Minerva Stomatol; 1985; 34(5):825-7. PubMed ID: 3866923
    [No Abstract]   [Full Text] [Related]  

  • 9. Potential role of beta-carotene in prevention of oral cancer.
    Garewal HS
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):294S-297S. PubMed ID: 1985401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smokeless tobacco and oral leukoplakia.
    Towle WM
    Aviat Space Environ Med; 1996 Jul; 67(7):662-3. PubMed ID: 8967889
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comment concerning the article by Sudbø J. in Läkartidningen 2001;98:4980-4].
    Milerad J
    Lakartidningen; 2006 Jul 12-25; 103(28-29):2112. PubMed ID: 19530393
    [No Abstract]   [Full Text] [Related]  

  • 12. The evolution of predictive oncology and molecular-based therapy for oral cancer prevention.
    Sudbø J; Reith A
    Int J Cancer; 2005 Jun; 115(3):339-45. PubMed ID: 15688375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction: Sudbø J et al. DNA content as a prognostic marker in patients with oral leukoplakia. N Engl J Med 2001;344:1270-8 and Sudbø J et al. The influence of resection and aneuploidy on mortality in oral leukoplakia. N Engl J Med 2004;350:1405-13.
    Curfman GD; Morrissey S; Drazen JM
    N Engl J Med; 2006 Nov; 355(18):1927. PubMed ID: 17079770
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel management of oral cancer: a paradigm of predictive oncology.
    Sudbø J
    Clin Med Res; 2004 Nov; 2(4):233-42. PubMed ID: 15931363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of oral cancer: beta-carotene and vitamin E in leukoplakia.
    Garewal H
    Eur J Cancer Prev; 1994 Mar; 3(2):101-7. PubMed ID: 8019381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Leukoplakia and erythroplakia--two orale precursor lesions].
    Grajewski S; Groneberg D
    Laryngorhinootologie; 2009 Oct; 88(10):666-72; quiz 673-5. PubMed ID: 19813163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSAIDs for the chemoprevention of oral cancer: promise or pessimism?: Commentary re J. L. Mulshine et al., randomized, double-blind, placebo-controlled, phase IIB trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia. Clin. Cancer Res., 10: 1565-1573, 2004.
    Goodin S; Shiff SJ
    Clin Cancer Res; 2004 Mar; 10(5):1561-4. PubMed ID: 15014004
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemoprevention of oral leukoplakia and chronic esophagitis in an area of high incidence of oral and esophageal cancer.
    Zaridze D; Evstifeeva T; Boyle P
    Ann Epidemiol; 1993 May; 3(3):225-34. PubMed ID: 8275193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of retinoids in chemoprevention of oral squamous cell carcinoma: an overview.
    Conley BA; Ord RA
    J Craniomaxillofac Surg; 1996 Dec; 24(6):339-45. PubMed ID: 9032601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemoprevention of oral cancer].
    Sudbø J
    Tidsskr Nor Laegeforen; 2003 May; 123(11):1518-21. PubMed ID: 12822012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.